CoChat

An International Validation of the “DECAF Score” to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE

Open access
Almarshoodi, Khadeijah, Echevarria, Carlos, Kassem, Abeer, Mahboub, Bassam, Salameh, Laila, Ward, Chris · 2024 · Hospital Pharmacy

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

The DECAF score (the Dyspnea, Eosinopenia, Consolidation, Academia, and Atrial fibrillation score) has been adopted in some hospitals to predict the severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). However, DECAF score has not been widely evaluated or used in Middle Eastern countries. The present study aimed to validate the DECAF score for predicting in-hospital mortality in patients with AECOPD in the United Arab Emirates (UAE). This was a retrospective, observational study conducted in 19 hospitals in the UAE. Data were retrieved from the electronic records of patients admitted for AECOPD in 17 hospitals across the country. Patients aged more than 35 years who were diagnosed with AECOPD were included in the study. The validation of the DECAF Score for inpatient death, 30-days death, and 90-day readmission was conducted using the Area Under the Receiver Operator curve (AUROC). The AUROCDECAF curves for inpatient death, 30-days death, and 90-day readmission were 0.8 (95% CI: 0.8-0.9), 0.8 (95% CI: 0.7-0.8), and 0.8 (95% CI: 0.8-0.8), respectively. The model was a satisfactory fit to the data (Hosmer–Lemeshow statistic = 0.195, Nagelkerke R 2 = 31.7%). There were significant differences in means of length of stay across patients with different DECAF score ( P = .008). Patients with a DECAF score of 6 had the highest mean length of stay, which was 29.8 ± 31.4 days. Patients with a DECAF score of 0 had the lowest mean length of stay, which was 3.6 ± 2.0 days. The DECAF score is a strong predictive tool for inpatient death, 30 days mortality and 90-day readmission in UAE hospital settings. The DECAF score is an effective tool for predicating mortality and other disease outcomes in patients with AECOPD in the UAE; hence, clinicians would be more empowered to make appropriate clinical decisions by using the DECAF score.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/00185787231209218

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. The distribution of Comorbidities (each patient can have more than 1).
Figure 1. The distribution of Comorbidities (each patient can have more than 1).CC BY-NC · PubMed Central
Figure 2. The frequency of medications used (each patient can take more than 1 medication.
Figure 2. The frequency of medications used (each patient can take more than 1 medication.CC BY-NC · PubMed Central
Figure 3. ROC curves for inpatient death, 30-day death, and 90-day death. This graph depicts the performance of the DECAF score model for predicting different death outcomes at 3 specific time points: during the hospital stay (inpatient death), within 30 days, and within 90 days. The curve plots the true positive rate (sensitivity) against the false positive rate (1-specificity) at various threshold settings. (a) ROC curve for inpatient death, (b) ROC curve for 30-day death, and (c) ROC curve for 90-day death.
Figure 3. ROC curves for inpatient death, 30-day death, and 90-day death. This graph depicts the performance of the DECAF score model for predicting different death outcomes at 3 specific time points: during the hospital stay (inpatient death), within 30 days, and within 90 days. The curve plots the true positive rate (sensitivity) against the false positive rate (1-specificity) at various threshold settings. (a) ROC curve for inpatient death, (b) ROC curve for 30-day death, and (c) ROC curve for 90-day death.CC BY-NC · PubMed Central
Figure 4. DECAF score versus the proportions of participants having arterial fibrillation (AF). Bars are calculated using standard deviation.
Figure 4. DECAF score versus the proportions of participants having arterial fibrillation (AF). Bars are calculated using standard deviation.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 1

  1. 10.1136/thoraxjnl-2015-207775 · DOI

Metadata

Authors
Almarshoodi, K., Echevarria, C., Kassem, A., Mahboub, B., Salameh, L., & Ward, C.
Affiliations
  • Newcastle University (GB)
  • Emirates Health Services, Ras AlKhaima, United Arab Emirates
  • Rashid Hospital (AE)
Corresponding author
Almarshoodi, Khadeijah
Venue
Hospital Pharmacy
Published
2023-11-03
Volume
59
Issue
2
Pages
234-240
ISSN
  • 0018-5787 (ISSN-L)
  • 1945-1253
OpenAlex
W4388293948
Cited by
8
References
20
Citations by year
2026: 2 · 2025: 3 · 2024: 3
FWCI
1.47
Type
journal article
Language
en
Open access
Locations
  • Hospital Pharmacy (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
Keywords
DECAF score, COPD exacerbations, chronic obstructive pulmonary disease, in-hospital mortality, 30-day mortality, hospital readmission, disease severity prediction, prognostic score validation, United Arab Emirates, length of hospital stay

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An International Validation of the “DECAF Score” to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE. https://app.cochat.ai/papers/10.1177/00185787231209218
The paper
Almarshoodi, K., Echevarria, C., Kassem, A., Mahboub, B., Salameh, L., & Ward, C. (2024). An International Validation of the “DECAF Score” to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE. Hospital Pharmacy. https://doi.org/10.1177/00185787231209218

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.